Karman Holdings Inc. is building its position in the aerospace and defense market as rising demand for missile systems, space-launch infrastructure and advanced defense...
Key Points:
Seven pricing events are listed for October 15, 2026, spanning companies, investment vehicles, and securities whose details remain incomplete in the supplied...
Iambic Therapeutics, Inc. has priced its initial public offering at $16 per share, seeking to raise approximately $150 million as the artificial intelligence-driven biotechnology...